Cellectis - ADR

+0.05 (+2.99%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)95.60M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$3.58 Million
Adjusted EPS-$0.42
See more estimates
10-Day MA$1.71
50-Day MA$1.96
200-Day MA$2.13
See more pivots

Cellectis - ADR Stock, NASDAQ:CLLS

8, rue de la Croix Jarry, Paris, Ile-de-France 75013
Phone: +
Number of Employees: 237


Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and Andr�© Choulika on February 20, 1999 and is headquartered in Paris, France.